WHAT IS BIOUPPER
BioUpper BioUpper is the first Italian Life Sciences platform that supports the best entrepreneurial projects through a structured approach providing access to trainings, resources and relationships within the innovation ecosystem and the medical/scientific sector. The goal of BioUpper is to support the best projects in order to transform them into actual business initiatives, thus actively contributing to the economic development of the Country and promoting youth employment.
BioUpper is the initiative promoted by Novartis Pharma and Fondazione Cariplo, in collaboration with IBM Italy, powered by Cariplo Factory and supported by Comin & Partners.
The life sciences startups will take part in Investor Day of the BioUpper 4. On January 28th, 2021, the best 9 startups of BioUpper – Call for Startup will meet the investors and discuss their growth and future.
CALL FOR STARTUP
Medere wins the fourth edition of BioUpper, the first Italian program of empowerment, acceleration, and accompaniment to the market in the field of Life Sciences, promoted by Novartis and the Fondazione Cariplo with the participation of IBM and the collaboration of Cariplo Factory.
Medere, distinguished itself with its solution for the ability to integrate with Novartis therapeutic areas and with IBM technology, will access the network of relationships in Silicon Valley made available by Novartis, IBM, and Cariplo, through “Novartis Biome” and other international networks of incubators that identify and support the development of highly innovative biomedical startups.